Entrar/Registro  
INICIO ENGLISH
 
Gaceta Médica de México
   
MENÚ

Contenido por año, Vol. y Num.

Índice de este artículo

Información General

Instrucciones para Autores

Mensajes al Editor

Directorio






>Revistas >Gaceta Médica de México >Año 2011, No. 6


Granados GM, Beltrán OA, Soto SBL, León TAM
Cirugía oncológica: evolución histórica y estado actual
Gac Med Mex 2011; 147 (6)

Idioma: Español
Referencias bibliográficas: 50
Paginas: 551-560
Archivo PDF: 114.68 Kb.


Texto completo




RESUMEN

La cirugía oncológica continúa siendo una parte fundamental en el manejo multidisciplinario de los pacientes con cáncer, a pesar de los avances actuales que se tienen en el campo de la radioterapia, quimioterapia, terapias sistémicas, incluyendo las terapias dirigidas a blancos moleculares. Su papel incide en varios momentos durante el manejo de un paciente oncológico como: prevención, diagnóstico, evaluación de la extensión de la enfermedad, tratamiento curativo, manejo de las secuelas, complicaciones por el tratamiento y, no menos importante, paliación.
El estado actual de la cirugía oncológica, producto de una constante evolución, impulsada por manos hábiles con mentes creativas e incansables, ha logrado marcar la historia de la medicina en un área que actualmente tiene gran trascendencia y con un crecimiento acelerado en un corto periodo de tiempo. Bajo este argumento nosotros hemos decidido presentar un panorama general actualizado del papel de la cirugía oncológica, desde su evolución a través de la historia hasta mostrar toda su aplicación en las distintas áreas del campo oncológico.


Palabras clave: Historia de la cirugía oncológica, Diagnóstico oncológico, Terapéutica oncológica.


REFERENCIAS

  1. Brunschwing H. Complete excision of pelvic viscera for advanced carcinoma. Cancer. 1948;1(2):177-83.

  2. Winchester DJ, Menck HR, Winchester DP. The National Cancer Data Base report on the results of a large nonrandomized comparison of breast preservation and modified radical mastectomy. Cancer. 1997;80(1):162-7.

  3. Volpe CM, Peterson S, Doerr RJ, Karakousis CP. Forequarter amputation with fasciocutaneous deltoid flap reconstruction for malignant tumors of the upper extremity. Ann Surg Oncol. 1997;4(4):298-302.

  4. Kapteijn BA, Nieweg OE, Liem I, et al. Localizing the sentinel node in cutaneous melanoma. gamma probe detection versus blue dye. Ann Surg Oncol. 1997;4(2):156-60.

  5. Walter L. Technologic innovations in surgery: a philosophic reflection on their impact on operations for cancer. Journal of Surgical Oncology. 2009;100:163-8.

  6. Fisher B. Biological research in the evolution of cancer surgery: a personal perspective. Cancer Res. 2008;68(24):10007-20.

  7. Taneja C, Cady B. Decreasing role of lymphatic system surgery. In surgical oncology. J Surg Oncol. 2005;89:61-6.

  8. Sakorafas GH, Farley DR. Optimal management of ductal carcinoma in situ of the breast. J Surg Oncol. 2003;12(4):221-40.

  9. Kadouri L, Hubert A, Rotenberg Y, et al. Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations. J Med Genet. 2007;44(7):467-71.

  10. Dowdy SC, Stefanek M, Hartmann LC. Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy. Am J Obstet Gynecol. 2004;191(4):1113-23.

  11. Bodner K, Bodner-Adler B, Wierrani F, Kimberger O, Denk C, Grunberger W. Is therapeutic conization sufficient to eliminate a high-risk HPV infection of the uterine cervix? A clinicopathological analysis. Anticancer Res. 2002;22(6B):3733-6.

  12. Pastore RL, Wolff BG, Hodge D. Total abdominal colectomy and ileorectal anastomosis for inflammatory bowel disease. Dis Colon Rectum. 1997;40(12):1455-64.

  13. Powell SM, Petersen GM, Krush AJ, et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med. 1993;329:1982-9.

  14. Dean PA. Hereditary intestinal polyposis syndromes. Rev Gastroenterol Mex. 1996;61(2):100-11.

  15. Onofre MA, Sposto MR, Navarro CM. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91(5):535-40.

  16. Welvaart K, Tijssen JG. Management of the undescended testis in relation to the development of cancer. J Surg Oncol. 1981;17(3):219-23.

  17. Schembre DB, Huang JL, Lin OS, Cantone N, Low DE. Treatment of Barrett’s esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Gastrointest Endosc. 2008;4: 595-601.

  18. Aletti G, Gallenberg M, Cliby W, Jatoi A, Hartmann L. Current management strategies for ovarian cancer. Mayo Clin Proc. 2007;82(6):751-70.

  19. Balch GC, Mithani SK, Richards KR, Beauchamp RD, Kelley MC. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Ann Surg Oncol. 2003;10(6): 616-21.

  20. Machi J, Oishi AJ, Mossing AJ, Furumoto NL, Oishi RH. Hand-assisted laparoscopic ultrasound-guided radiofrequency thermal ablation of liver tumors: a technical report. Surg Laparosc Endosc Percutan Tech. 2002;12(3):160-4.

  21. Leen E, Horgan P. Radiofrequency ablation of colorectal liver metastases. Surgical Oncology. 2007;16:47-51.

  22. Kitano S, Kitajima M, Konishi F, Kondo H, Satomi S, Shimizu N; Japanese Laparoscopic Surgery Study Group. A multicenter study on laparoscopic surgery for colorectal cancer in Japan. Surg Endosc. 2006;20(9):1348-52.

  23. Teknos TN, Hogikyan ND, Wolf GT. Conservation laryngeal Surgery for malignant tumours of the larynx and pyriform sinus. Hematol Oncol Clin North Am. 2001;15(2):1-13.

  24. Steiner W, Ambrosch P. Endoscopic laser surgery of the upper aerodigestive tract. With special emphasis on cancer. Surgery. First Ed. Suttgart, Alemania: Georg Thieme Verlag; 2000.

  25. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995;333:1456.

  26. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233.

  27. Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomized trials on 1,973 patients. Eur J Cancer. 1995; 31A:1574.

  28. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347:1227.

  29. Vvan Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial. J Natl Cancer Inst. 2000;92:1143.

  30. Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995;332:907.

  31. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer. 2003;98:697.

  32. Arriagada R, Le MG, Rochard F, Contesso G. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol. 1996;14:1558.

  33. Esquivel J, Sticca R, Sugarbaker PH, et al Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Oncol. 2007;14:128-33.

  34. Granados-García M, Aguilar Ponce JL, Luna-Ortiz K, Maldonado F, Lavin-Lozano A. El tratamiento multidisciplinario del cáncer de las vías aerodigestivas superiores. Cancerología. 2007;2(1):27-38.

  35. Averette HE, Lichtinger M, Sevin BU, Girtanner RE. Pelvic exenteration: a 15-year experience in a General Metropolitan Hospital. Am J Obstetr Gynecol. 1984;150(2):179-84.

  36. López-Graniel CM, Castilleros PC, Jiménez Ríos MA, et al. Exenteración pélvica en el Instituto Nacional de Cancerología. Rev Inst. Nal Cancerol. 1999;45(4):230-43.

  37. Robles VC, López Graniel CM, Lizano SM. Cáncer cérvico-uterino. Cirujano General. 1999;21(1):19-24.

  38. Black C, Marotti J, Zarovnaya E, Paydarfar J. Critical evaluation of frozen section margins in head and neck cancer resections. Cancer. 2006;107:2792-800.

  39. Rivas B, Carrillo JF, Granados GM. Oromandíbular reconstruction for oncological purposes. Ann Plast Surg. 2000;44:29-35.

  40. Santamaría-Linares E, Granados-García M, Barrera-Franco JL. Radial forearm free tissue transfer for head and neck reconstruction: versatility and reliability of a single donor site. Microsurgery. 2000;20:195-201.

  41. Biffi R, Pozzi S, Agazzi A, et al. Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients. Ann Oncol. 2004;15(2):296-300.

  42. Licitra L, Grandi C, Guzzo M, et al. Primary Chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol. 2003;21:327-33.

  43. Bacci G, Longhi A, Fagioli F, Briccoli A, Versari M, Picci P. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy. Eur J Cancer. 2005;41(18):2836-45.

  44. Forastieri AA, Goepfert H, Major M, Pajak TF, Weber R, Morrison W. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. New Engl J Med. 2003;349:2091-8.

  45. Pace M, Gattai R, Matteini M, Macera Mascitelli E, Bechi P. Toxicity and morbility after isolated lower limb perfusion in 242 chemo-hyperthermal treatments for cutaneous melanoma. The experience of the Tuscan Reference Centre. J Exp Clin Cancer Res. 2008;27(1):67.

  46. Christoforidis D, Martinet O, Lejeune FJ, Mosimann F. Isolated liver perfusion for non-resectable liver tumors: a review. Eur J Surg Oncol. 2002;28:875-90.

  47. De Bree E, Witkamp AJ, Zoetmulder FN. Intraperitoneal chemotherapy for colorectal cancer. J Surg Oncol. 2002;79:46-61.

  48. Kretzler A, Molls M, Gradinger R, Lukas P, Steinau HU, Wurschmidt F. Intraoperative radiotherapy of soft tissue sarcoma of the extremity. Strahlenther Onkol. 2004;180(6):365-70.

  49. Mercadante S. Parenteral versus enteral nutrition in cancer patients: indications and practice. Support Care Cancer. 1998;6:85-93.

  50. Barrera R. Nutritional support in cancer patient. JPEN. 2002;26(5):s63-71.



>Revistas >Gaceta Médica de México >Año2011, No. 6
 

· Indice de Publicaciones 
· ligas de Interes 






       
Derechos Resevados 2019